PCR Technologies Market Growth, Drivers, and Opportunities

Overview

The global PCR technologies market growth forecasted to transform from USD 14.61 Billion in 2024 to USD 21.89 Billion by 2030, driven by a CAGR of 7.0%.

Many factors that drive market growth are interlinked. For instance, advancements in technology support growth. Simultaneously, application in diagnostic labs increases their use in various healthcare settings. There is also a more significant trend in personalized medicine, driving the demand for this market. Higher applications in life sciences, such as disease detection, genomics, and cell analysis, further expand its application. Increased investment by the public and private sector and higher awareness increases the application of this device.

The escalating prevalence of infectious diseases has prompted organisations such as the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) of the US to facilitate the approval processes of PCR testing devices along with other associated technologies. Notably in the era of COVID-19, such speedy approvals have been beneficial in addressing efficiently the management of public health crises and in the quick deployment of diagnostic solutions. Considering these aspects, Government agencies tend to be influential in an economy and as such, the market for PCR technology is relatively more active encouraging the market’s resilience to emerging health challenges.

Attractive Opportunities in the PCR Technologies Market

North America

The increasing incidence of infectious diseases and constant improvements in creating innovative PCR technologies play a vital role in the North American market growth.

The development of novel and innovative products and company initiatives, such as partnerships, product launches, approvals and acquisitions, have supported market growth.

The rise in the development of advanced technologies such as digital PCR, multiplex PCR, and high-throughput PCR systems is an emerging opportunity for the prominent market players.

North America held the largest share of 44.5% of the PCR technologies market in 2023.

Market growth will be supported by increasing funding, the automation in PCR, and an increasing demand for molecular diagnostics.

Global PCR Technologies Market Dynamics

Driving Forces: Technological Advancement

Advances in technology have dramatically improved the sensitivity, specificity, and efficiency of PCR techniques. Newer techniques, such as real-time PCR and digital PCR, have undergone a drastic transformation that makes them more sensitive and precise. Indeed, applications of PCR have dramatically increased within the past few years. It has become a tool for genetic research and personalized medicine. Furthermore, PCR has become more accessible by coupling it with microfluidics and further advanced automation, making it more efficient in the laboratory. New reagents improve the quality and consistency of the results of PCR. Further research in such technologies will offer new opportunities in research and diagnostics.

Also, there has been several progressions due to the miniaturization of point-of-care testing (PoCT)-PCR technology, which includes shortening assay times, reducing reagent volumes, and performing rapid thermal cycling. Notably, the impact of these miniaturized systems has been felt during public health emergencies such as the COVID-19 pandemic, as they facilitated the rapid diagnosis and management of outbreaks. rephrase it in business professional language. Repeated cycle techniques like PCR.Ai have been incorporated in a PCR workflow to make laboratory testing simple and less time consuming by automating the processes of interpreting and validating results. All these technologies advancements helps in growing demand for PCR products in the market.

Restraining Factors: High Costs of Equipment

High investments required to maintain such systems have been one of the factors restraining the market's growth, mainly amongst small laboratories and healthcare facilities in developing countries, which cannot readily compete with such prices. The high capital requirement for highly advanced PCR instruments discourages many low-capital institutions from implementing PCR technology routinely for diagnosis and research. Such direct financial costs can disadvantage critical applications like infectious disease detection and genetic evaluations. Maintenance costs, consumables, personnel training, and technical support also enhance the long-term sustainability of PCR technology. Laboratories can incur heavy costs associated with acquisition of PCR instruments such as standard PCR, qPCR, RT-PCR machines. The price range is wide owing to the kind, features and operational capabilities of the apparatus in question. The cost is escalating due to factors such as automation, the volume of throughput, how much activities can be multiplexed and their sensitivity. During long and extensive testing operations such as those conducted during the outbreak of the COVID-19 diseases, a need for more than one equipment necessitated substantial construction costs, thereby emphasizing the impact of new developments in technology on healthcare facilities and research organizations.

Opportunities: Emerging Application of PCR Technology

PCR is highly applied in liquid biopsies to analyze circulating tumor DNA (ctDNA) in blood samples. It is a non-invasive method with which it is possible to detect cancer early, monitor progression, and assess the efficiency of treatments after identifying specific genetic changes of ctDNA. PCT Technology is also incorporated into point-of-care diagnostic equipment to diagnose infectious diseases rapidly, such as COVID-19, HIV, and influenza. Such advancements as isothermal PCR and microfluidic PCR systems enable susceptible and precise tests even outside the confines of a lab. This way, it delivers speedy results for health professionals to hasten treatment decisions, especially in regions with less advanced medical infrastructure.

Genomic medicine is increasingly incorporating digital polymerase chain reaction (dPCR) technology into its usage especially for minimal residual disease monitoring, rare mutation screening, and gene expression assaying. Its high sensitivity and quantitative power greatly suit these applications. Recent developments in techniques like photonic PCR and extreme PCR, which enhance amplification and detection rates, justify the use of these techniques even in point of care, rapid testing environments.

Challenges: Inhibition and Sensitivity

The significant inhibitory challenges in PCR technologies are inhibition and sensitivity, making these technologies less precise and ineffective in all applications. PCR processes are prone to inhibitors in biological samples like blood, soil, or food. Such an inhibitor can interfere with the DNA polymerase enzyme's ability to amplify DNA. Some examples of these inhibitors include substances like hemoglobin, bile salts, and chemicals from DNA extraction procedures. When it is present, it can block or even totally prevent the amplification of the DNA, which leads to false negatives or partial results.

Despite being extremely sensitive, there are certain limitations. PCR does not amplify DNA efficiently at low concentrations of the target, like infections in the early stages of a disease or those genetic mutations that occur in less than one percent of a population. External DNA contamination is also shown as false positives. The challenge here is maintaining the sensitivity of the technique whereby the minimal amounts of DNA can be sensed without allowing contamination or non-specific amplification, which remains a significant issue in PCR technologies.

Global PCR Technologies Market Ecosystem Analysis

The PCR technologies market ecosystem includes various product, technique, applications. PCR technologies manufacturers are manufacturing, qPCR instruments, RT-PCR instruments, thermal cyclers, reagents, consumables, softwares and other systems. These products are essential applications such as environment, genetic sequencing, genotyoping, diagnostics etc. Other than this the end users includes laboratories (hospital based and diagnostic), research organisations, pharmaceutical & biotechnological companies.

Reagents and consumables to register most significant market share during study period

In PCR, the reagents are the chemicals necessary to amplify DNA, including the primer, nucleotides, DNA polymerase, buffers, etc. The consumables are single-use items such as PCR tubes, plates, pipette tips, and sealing films, used in every PCR procedure but discarded afterward. Reagents and consumables constitute the largest market share for PCR technologies since they are essential for every PCR, unlike PCR instruments. It includes new reagents, such as primers, nucleotides, enzymes, and consumables in tubes and plates. There is a steady demand for high-throughput laboratories for diagnostics and research in which multiple PCR tests can run. Moreover, the vast range of applications in clinical diagnostics, genetic research, and forensic analysis often need specialized reagents, which drives up the market share in this segment.The advent of disease diagnosis through PCR, more particularly after the onset of COVID-19, has significantly increased the consumption of reagents such as enzymes, primers, probes, among other consumables. However, the development of new formulative reagents has brought in additional usage as they have enhanced the sensitivity and specificity and enabled multiplexing. Given all these factors, the demand growth of the reagent market is likely to persist for as long as there are clinical diagnostics and research undertakings in the broader phenomenon of PCT technology, which incorporates PCR technology.

Diagnostic laboratories to hold largest share in end-user market from 2024 to 2030

Diagnostic laboratories are leaders in the PCR market since they play a critical role in diagnosing and prognostic diseases. PCR is commonly used for diagnosing infectious diseases such as novel COVID-19, HIV, and hepatitis; genetic diseases; and cancer because of the accuracy and quick generation of results. The continued use of PCR technologies in the market for screening and real-time testing boosts the need for molecular diagnostics, driving growth in this market. Aside from that, the appearance of personalized medicine and high awareness of the early detection of diseases has heightened their dependency on PCR in such laboratories. Moreover, the persistent requirement for routine tests, especially during pandemics and epidemics, further enhances their market presence. The demand for PCR technology is on rise since the diagnostic labs have to carry out extensive testing in different disease areas such as infectious diseases, cancer or genetic disorders. Furthermore, the importance of diagnostic laboratories as the main consumers of PCR technology has also been strengthened owing to the increasing attention being given to molecular diagnostics in the context of precision medicine as well as in the search for new pathogens.

Asia Pacific register highest CAGR in PCR technologies market during forecast period

The Asia-Pacific region has the highest CAGR in the PCR market because of several factors. The rising infectious diseases and chronic conditions will increase demand for advanced diagnostic tools such as PCR. In addition, higher investments in healthcare infrastructure, particularly in China and India, have fuelled the adoption of PCR technologies. The expansion of research and development activities, government initiatives to increase the accessibility of healthcare, and the expansion of the pharmaceutical and biotechnology industry are further boosting these higher growth rates. A large population in the region, with more significant medical tourism, is expanding the market further and has rapidly enhanced the demand for PCR technologies.

Asia Pacific has become one of the leading regions for carrying out clinical trials and diagnostic testing, owing to lower costs and the availability of skilled personnel, which is causing demand for PCR technology to increase. The increasing emphasis on precision medicine, as well as the rapid growth of the biotechnology sector in the region, has resulted in a higher adoption of PCR technologies. The wave of investment in PCR technology for mass testing and research activities fueled by the Covid 19 pandemic has led to significant growth in the market in the region.

HIGHEST CAGR MARKET IN 2023

CHINA FASTEST GROWING MARKET IN THE REGION

Recent Developments of PCR Technologies Market

Agreements: In 2023, Bio-Rad Laboratories, Inc. and QIAGEN entered into an agreement to settle their patent dispute pending in the US District Court of Delaware according to a global settlement and patent cross-licensing agreement relating to digital PCR technology.

Partnership: In 2023, Thermo Fisher Scientific (US) partnered with Pfizer (US) to gain access to NGS-associated testing for cancer.

Acquisition: In 2024, F. Hoffman-La Roche Ltd. (Switzerland) acquired TIB Molbiol (Germany) to include infectious diseases in its PCR products portfolio.

Agreement: In 2022, Bio-Rad Laboratories Inc. (US) entered into an agreement with NuProbe (US) to expand its business to multiplexed digital PCR assays.

Key Market Players

KEY PLAYERS IN THE PCR TECHNOLOGIES MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in PCR Technologies Market?

Unlock Insights

Scope of the Report

Report Metric	Details
Market size available for years	2022-2030
Base Year Considered	2023
Forecast period	2024-2030
Forecast units	Value (USD Million/USD Billion)
Segments covered	Product, Technique, Application, End User, and Region
Geographies covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Key Questions Addressed by the Report

What will the market share of the global technologies market be within five years?

The PCR technologies market is projected to reach USD 21.89 Billion by 2030 from USD 14.61 in 2024, growing at a CAGR of 7.0% during the forecast period.

Which product type segment has the largest share in the PCR technologies market?

Reagents and consumables are expected to exhibit the largest share.

What major strategies are leading players adopting to enter emerging regions?

Agreements, partnerships, collaboration, expansion, product launches, and product approvals represent the major growth strategies adopted by major market players.

What are the major factors likely to hamper the growth of the PCR technologies market?

Premium costs, technical limitations of PCR equipment, and stringent regulatory guidelines associated with medical devices can restrict the growth of the PCR technologies market.

Which end-user segment will likely show the highest growth in the PCR technologies market?

Diagnostic Laboratories are expected to grow at the highest rate in the end-user market.

Adjacent Markets

Request Bundle Reports

Personalize This Research

Triangulate with your Own Data
Get Data as per your Format and Definition
Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
Any level of Personalization

Request A Free Customisation

Let Us Help You

What are the Known and Unknown Adjacencies Impacting the PCR Technologies Market
What will your New Revenue Sources be?
Who will be your Top Customer; what will make them switch?
Defend your Market Share or Win Competitors
Get a Scorecard for Target Partners

Customized Workshop Request

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

RESEARCH METHODOLOGY

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS

DRIVERS

- Increasing outbreaks of infectious diseases/viral persistence

- Development of miniaturized and portable point-of-care testing devices

- Integration of PCR technology with automation and data analysis tools

- High demand for technologically advanced molecular diagnostics

RESTRAINTS

- Premium product pricing

- Dearth of skilled healthcare professionals

OPPORTUNITIES

- Increased investments in laboratory infrastructure

- Rising number of applications in rare sequence detection

CHALLENGES

- Technical limitations

- Increased pricing pressure on market players
5.3 VALUE CHAIN ANALYSIS

RESEARCH & DEVELOPMENT

RAW MATERIAL PROCUREMENT AND MANUFACTURING

DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.4 PORTER’S FIVE FORCES ANALYSIS

THREAT OF NEW ENTRANTS

THREAT OF SUBSTITUTES

BARGAINING POWER OF SUPPLIERS

BARGAINING POWER OF BUYERS

INTENSITY OF COMPETITIVE RIVALRY
5.5 KEY STAKEHOLDERS AND BUYING CRITERIA

KEY STAKEHOLDERS IN BUYING PROCESS

KEY BUYING CRITERIA
5.6 PATENT ANALYSIS

LIST OF MAJOR PATENTS
5.7 KEY CONFERENCES AND EVENTS, 2024–2025
5.8 TRADE DATA ANALYSIS

IMPORT DATA FOR HS CODE 3822

EXPORT DATA FOR HS CODE 3822
5.9 PRICING ANALYSIS

PRICE TRENDS OF PCR TECHNOLOGIES, BY REGION

INDICATIVE SELLING PRICE OF PCR TECHNOLOGY PRODUCTS, BY REGION, 2021–2023

AVERAGE SELLING PRICE TREND, BY REGION

- Average selling price trend of PCR technology equipment, by region

- Average selling price trend of PCR instruments, by key player
5.10 UNMET NEEDS AND KEY PAIN POINTS
5.11 ECOSYSTEM ANALYSIS
5.12 SUPPLY CHAIN ANALYSIS

MANUFACTURING COMPANIES

SALES & DISTRIBUTION AGENTS

END USERS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.14 TECHNOLOGY ANALYSIS

KEY TECHNOLOGIES

- Thermal cyclers

- Real-time quantitative PCR

- Portable and point-of-care PCR

COMPLEMENTARY TECHNOLOGIES

- Next-generation sequencing

- Microarrays

- Lab-on-a-chip devices

- Robotics and automation

ADJACENT TECHNOLOGIES

- Mass spectrometry

- Single-cell sequencing

- Fluorescence in situ hybridization
5.15 REGULATORY LANDSCAPE

REGULATORY ANALYSIS

- North America

- Europe

- Asia Pacific

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.16 INVESTMENT AND FUNDING SCENARIO
5.17 REIMBURSEMENT SCENARIO ANALYSIS
5.18 IMPACT OF AI/GEN AI ON PCR TECHNOLOGIES MARKET

PCR TECHNOLOGIES MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 REAGENTS AND CONSUMABLES

INCREASING USE OF DPCR-BASED ANALYTICAL PROCEDURES IN GENETIC RESEARCH AND FORENSICS TO DRIVE MARKET
6.3 INSTRUMENTS

RISING AVAILABILITY OF TECHNOLOGICALLY ADVANCED AND INNOVATIVE PCR INSTRUMENTS TO FUEL MARKET GROWTH
6.4 SOFTWARE AND SERVICES

GROWING DEMAND FOR SPECIALIZED PCR ANALYSIS SOFTWARE FOR ONCOLOGY STUDIES AND FORENSICS TO SPUR MARKET GROWTH

PCR TECHNOLOGIES MARKET, BY TECHNIQUE

7.1 INTRODUCTION
7.2 REAL-TIME PCR

RISING ADOPTION OF REAL-TIME PCR AMONG RESEARCHERS AND HEALTHCARE PROFESSIONALS TO PROPEL MARKET GROWTH
7.3 CONVENTIONAL PCR

COST-EFFECTIVENESS AND EASE OF USAGE IN ROUTINE CLONING, GENOTYPING, AND MUTATION ANALYSIS TO FUEL MARKET GROWTH
7.4 DIGITAL PCR

FASTER RESULTS WITH LOWER MARGIN ERRORS TO DRIVE ADOPTION
7.5 REVERSE TRANSCRIPTION PCR

HIGHER SENSITIVITY FOR MEASURING CHANGES IN GENE EXPRESSION TO AUGMENT MARKET GROWTH
7.6 HOT-START PCR

BETTER REACTION SPECIFICITY WITH LOWER ERROR RATES TO FAVOR MARKET GROWTH
7.7 MULTIPLEX PCR

COST-EFFECTIVENESS AND HIGH THROUGHPUT TO AID MARKET GROWTH
7.8 OTHER PCR TECHNIQUES

PCR TECHNOLOGIES MARKET, BY APPLICATION

120

8.1 INTRODUCTION
8.2 DIAGNOSTIC APPLICATIONS

UNAVAILABILITY OF REIMBURSEMENTS FOR CLINICAL DIAGNOSTIC TESTS TO LIMIT MARKET GROWTH
8.3 GENOTYPING

LARGE TARGET PATIENT POPULATION FOR CANCER DIAGNOSIS TO AUGMENT MARKET GROWTH
8.4 NUCLEIC ACID DETECTION

RISING PREVALENCE OF INFECTIOUS DISEASES TO BOOST MARKET GROWTH
8.5 GENE EXPRESSION ANALYSIS

INCREASED R&D FUNDING AND GRANTS FOR PCR TO FAVOR MARKET GROWTH
8.6 NUCLEIC ACID SYNTHESIS

INCREASED FOCUS ON PERSONALIZED AND PRECISE MEDICINES TO SUPPORT MARKET GROWTH
8.7 GENETIC SEQUENCING

TECHNOLOGICAL IMPROVEMENTS AND REDUCED COSTS OF SEQUENCING TO FUEL MARKET GROWTH
8.8 ENVIRONMENTAL APPLICATIONS

STRICT GOVERNMENT ENVIRONMENTAL POLICIES TO PROMOTE USE OF PCR
8.9 STANDARD VALIDATION/VERIFICATION

NEED FOR REGIONAL/GLOBAL VALIDATION FOR COMMERCIAL/NON-COMMERCIAL GUIDELINE FRAMING TO DRIVE MARKET
8.10 OTHER APPLICATIONS

PCR TECHNOLOGIES MARKET, BY END USER

131

9.1 INTRODUCTION
9.2 HOSPITAL LABORATORIES

RISING PUBLIC AWARENESS OF ROUTINE CHECKUPS TO SUPPORT MARKET GROWTH
9.3 DIAGNOSTIC LABORATORIES

ESTABLISHMENT OF INDEPENDENT SPECIALIZED DIAGNOSTIC LABORATORIES TO PROPEL MARKET GROWTH
9.4 ACADEMIC AND GOVERNMENT ORGANIZATIONS

INCREASED GOVERNMENT SUPPORT FOR GENOME-BASED RESEARCH TO DRIVE MARKET
9.5 PHARMA-BIOTECH COMPANIES

INCREASING R&D INITIATIVES BY PHARMA-BIOTECH COMPANIES TO DRIVE ADOPTION OF PCR TECHNOLOGIES
9.6 OTHER END USERS

PCR TECHNOLOGIES MARKET, BY REGION

138

10.1 INTRODUCTION
10.2 NORTH AMERICA

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

US

- US to dominate North American PCR technologies market during study period

CANADA

- Supportive government initiatives for genomics research to aid market growth
10.3 EUROPE

MACROECONOMIC OUTLOOK FOR EUROPE

GERMANY

- Presence of well-established pharmaceutical and R&D industry to augment market growth

FRANCE

- Increasing investments in life science R&D for infrastructural development to favor market growth

UK

- Rising acceptance of genome-based diagnosis by clinicians and healthcare professionals to spur market growth

ITALY

- Supportive government policies and high healthcare expenditure to boost market growth

SPAIN

- Increasing funding for life science research and pharmaceutical drug development to boost market growth

REST OF EUROPE
10.4 ASIA PACIFIC

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

CHINA

- Improved public access to modern healthcare facilities and advanced genomics research to fuel market growth

JAPAN

- Well-established healthcare infrastructure and advanced cancer research activities to support market growth

INDIA

- Presence of large target patient population and high government healthcare expenditure to support market growth

AUSTRALIA

- High healthcare expenditure to drive adoption of advanced PCR technologies

SOUTH KOREA

- Improved medical tourism and prevalence of chronic diseases to propel market growth

REST OF ASIA PACIFIC
10.5 LATIN AMERICA

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

BRAZIL

- Growing focus on proteomics and genomics research to drive market

MEXICO

- Favorable trade agreements to support imports and improve accessibility to PCR instruments

REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA

MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

GCC COUNTRIES

- Advancements in healthcare infrastructure and increased focus on personalized medicines to fuel market growth

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

195

11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN

OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PCR TECHNOLOGIES MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023

GLOBAL PCR INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2023

GLOBAL PCR REAGENTS AND CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2023

GLOBAL PCR SOFTWARE AND SERVICES MARKET SHARE, BY KEY PLAYER, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023

STARS

EMERGING LEADERS

PERVASIVE PLAYERS

PARTICIPANTS

COMPANY FOOTPRINT: KEY PLAYERS, 2023

- Company footprint

- Product footprint

- Application footprint

- Technique footprint

- End-user footprint

- Region footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023

PROGRESSIVE COMPANIES

RESPONSIVE COMPANIES

DYNAMIC COMPANIES

STARTING BLOCKS

COMPANY BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.8 PRODUCT/BRAND COMPARISON
11.9 COMPETITIVE SCENARIO

PRODUCT LAUNCHES AND APPROVALS

DEALS

COMPANY PROFILES

215

12.1 KEY PLAYERS

THERMO FISHER SCIENTIFIC INC.

- Business overview

- Products/Services/Solutions offered

- Recent developments

- MnM view

F. HOFFMANN-LA ROCHE LTD.

- Business overview

- Products/Services/Solutions offered

- Recent developments

- MnM view

AGILENT TECHNOLOGIES, INC.

- Business overview

- Products/Services/Solutions offered

- Recent developments

- MnM view

BIO-RAD LABORATORIES, INC.

- Business overview

- Products/Services/Solutions offered

- Recent developments

- MnM view

QIAGEN

- Business overview

- Products/Services/Solutions offered

- Recent developments

- MnM view

DANAHER CORPORATION

- Business overview

- Products/Services/Solutions offered

- Recent developments

ABBOTT

- Business overview

- Products/Services/Solutions offered

- Recent developments

TAKARA BIO INC.

- Business overview

- Products/Services/Solutions offered

- Recent developments

ANALYTIK JENA GMBH+CO. KG

- Business overview

- Products/Services/Solutions offered

- Recent developments

MERCK KGAA

- Business overview

- Products/Services/Solutions offered

BIONEER CORPORATION

- Business overview

- Products/Services/Solutions offered

PERKINELMER

- Business overview

- Products/Services/Solutions offered

- Recent developments

BECTON, DICKINSON AND COMPANY

- Business overview

- Products/Services/Solutions offered

- Recent developments

STANDARD BIOTOOLS

- Business overview

- Products/Services/Solutions offered

HOLOGIC, INC.

- Business overview

- Products/Services/Solutions offered

- Recent developments

LONZA

- Business overview

- Products/Services/Solutions offered

ILLUMINA, INC.

- Business overview

- Products/Services/Solutions offered

SANSURE BIOTECH INC.

- Business overview

- Products/Services/Solutions offered
12.2 OTHER PLAYERS

PROMEGA CORPORATION

LIMING BIO

EPPENDORF SE

TRANSGEN BIOTECH CO., LTD.

DAAN GENE CO., LTD.

BIOBASE GROUP

NIPPON GENETICS EUROPE

BIOMÉRIEUX

DAIICHI SANKYO COMPANY, LIMITED

STILLA

GENSCRIPT

APPENDIX

296

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 PCR TECHNOLOGIES MARKET: STUDY ASSUMPTIONS
TABLE 2 PCR TECHNOLOGIES MARKET: RISK ASSESSMENT
TABLE 3 NUMBER OF REPORTED CASES OF INFECTIOUS DISEASES, JANUARY 2019–DECEMBER 2022
TABLE 4 ADVANTAGES AND DISADVANTAGES OF REAL-TIME POINT-OF-CARE RT-PCR DEVICES
TABLE 5 PCR TECHNOLOGIES MARKET: PORTER’S FIVE FORCES
TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%)
TABLE 7 PCR TECHNOLOGIES MARKET: LIST OF MAJOR PATENTS, JANUARY 2022–DECEMBER 2024
TABLE 8 PCR TECHNOLOGIES MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
TABLE 9 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 10 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019−2023 (USD THOUSAND)
TABLE 11 INDICATIVE SELLING PRICE OF PCR TECHNOLOGY PRODUCTS, BY REGION, 2021–2023 (USD)
TABLE 12 AVERAGE SELLING PRICE OF PCR INSTRUMENTS, BY KEY PLAYER, 2023 (USD)
TABLE 13 PCR TECHNOLOGIES MARKET: CURRENT UNMET NEEDS
TABLE 14 PCR TECHNOLOGIES MARKET: ROLE IN ECOSYSTEM
TABLE 15 US: CLASSIFICATION OF PCR TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES
TABLE 16 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 17 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 18 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 19 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 REIMBURSEMENT CODES FOR PCR TESTING, 2023
TABLE 26 PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 27 PCR TECHNOLOGIES MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2022–2030 (USD MILLION)
TABLE 28 PCR TECHNOLOGIES MARKET FOR INSTRUMENTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 29 PCR TECHNOLOGIES MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2022–2030 (USD MILLION)
TABLE 30 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 31 REAL-TIME PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 32 REAL-TIME PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 33 REAL-TIME PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 34 REAL-TIME PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 35 CONVENTIONAL PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 36 CONVENTIONAL PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 37 CONVENTIONAL PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 38 CONVENTIONAL PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 39 DIGITAL PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 40 DIGITAL PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 41 DIGITAL PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 42 DIGITAL PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 43 ONE-STEP RT-PCR VS. TWO-STEP RT-PCR
TABLE 44 REVERSE TRANSCRIPTION PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 45 REVERSE TRANSCRIPTION PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 46 REVERSE TRANSCRIPTION PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 47 REVERSE TRANSCRIPTION PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 48 BENEFITS AND CONSIDERATIONS OF HOT-START PCR TECHNOLOGY
TABLE 49 HOT-START PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 50 HOT-START PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 51 HOT-START PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 52 HOT-START PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 53 MULTIPLEX PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 54 MULTIPLEX PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 55 MULTIPLEX PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 56 MULTIPLEX PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 57 OTHER PCR TECHNIQUES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 58 OTHER PCR TECHNIQUES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 59 OTHER PCR TECHNIQUES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 60 OTHER PCR TECHNIQUES MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 61 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 62 PCR TECHNOLOGIES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
TABLE 63 PCR TECHNOLOGIES MARKET FOR GENOTYPING, BY REGION, 2022–2030 (USD MILLION)
TABLE 64 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID DETECTION, BY REGION, 2022–2030 (USD MILLION)
TABLE 65 PCR TECHNOLOGIES MARKET FOR GENE EXPRESSION ANALYSIS, BY REGION, 2022–2030 (USD MILLION)
TABLE 66 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID SYNTHESIS, BY REGION, 2022–2030 (USD MILLION)
TABLE 67 PCR TECHNOLOGIES MARKET FOR GENETIC SEQUENCING, BY REGION, 2022–2030 (USD MILLION)
TABLE 68 PCR TECHNOLOGIES MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
TABLE 69 PCR TECHNOLOGIES MARKET FOR STANDARD VALIDATION/VERIFICATION, BY REGION, 2022–2030 (USD MILLION)
TABLE 70 PCR TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
TABLE 71 PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 72 PCR TECHNOLOGIES MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2022–2030 (USD MILLION)
TABLE 73 PCR TECHNOLOGIES MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022–2030 (USD MILLION)
TABLE 74 PCR TECHNOLOGIES MARKET FOR ACADEMIC AND GOVERNMENT ORGANIZATIONS, BY REGION, 2022–2030 (USD MILLION)
TABLE 75 PCR TECHNOLOGIES MARKET FOR PHARMA-BIOTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)
TABLE 76 PCR TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 77 PCR TECHNOLOGIES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 78 NORTH AMERICA: KEY MACROINDICATORS
TABLE 79 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 80 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 81 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 82 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 83 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 84 US: KEY MACROINDICATORS
TABLE 85 US: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 86 US: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 87 CANADA: KEY MACROINDICATORS
TABLE 88 CANADA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 89 CANADA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 90 EUROPE: KEY MACROINDICATORS
TABLE 91 EUROPE: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 92 EUROPE: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 93 EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 94 EUROPE: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 95 EUROPE: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 96 GERMANY: KEY MACROINDICATORS
TABLE 97 GERMANY: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 98 GERMANY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 99 FRANCE: KEY MACROINDICATORS
TABLE 100 FRANCE: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 101 FRANCE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 102 UK: KEY MACROINDICATORS
TABLE 103 UK: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 104 UK: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 105 ITALY: KEY MACROINDICATORS
TABLE 106 ITALY: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 107 ITALY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 108 SPAIN: KEY MACROINDICATORS
TABLE 109 SPAIN: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 110 SPAIN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 111 REST OF EUROPE: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 112 REST OF EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 113 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 114 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 115 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 116 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 117 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 118 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 119 CHINA: KEY MACROINDICATORS
TABLE 120 CHINA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 121 CHINA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 122 JAPAN: KEY MACROINDICATORS
TABLE 123 JAPAN: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 124 JAPAN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 125 INDIA: KEY MACROINDICATORS
TABLE 126 INDIA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 127 INDIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 128 AUSTRALIA: KEY MACROINDICATORS
TABLE 129 AUSTRALIA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 130 AUSTRALIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 131 SOUTH KOREA: KEY MACROINDICATORS
TABLE 132 SOUTH KOREA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 133 SOUTH KOREA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 134 REST OF ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 135 REST OF ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 136 LATIN AMERICA: KEY MACROINDICATORS
TABLE 137 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 138 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 139 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 140 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 141 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 142 BRAZIL: KEY MACROINDICATORS
TABLE 143 BRAZIL: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 144 BRAZIL: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 145 MEXICO: KEY MACROINDICATORS
TABLE 146 MEXICO: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 147 MEXICO: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 148 REST OF LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 149 REST OF LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 152 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 156 GCC COUNTRIES: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 157 GCC COUNTRIES: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 158 REST OF MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 159 REST OF MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 160 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PCR TECHNOLOGIES MARKET
TABLE 161 PCR TECHNOLOGIES MARKET: DEGREE OF COMPETITION
TABLE 162 PCR TECHNOLOGIES MARKET: PRODUCT FOOTPRINT
TABLE 163 PCR TECHNOLOGIES MARKET: APPLICATION FOOTPRINT
TABLE 164 PCR TECHNOLOGIES MARKET: TECHNIQUE FOOTPRINT
TABLE 165 PCR TECHNOLOGIES MARKET: END-USER FOOTPRINT
TABLE 166 PCR TECHNOLOGIES MARKET: REGION FOOTPRINT
TABLE 167 PCR TECHNOLOGIES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 168 PCR TECHNOLOGIES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 169 PCR TECHNOLOGIES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
TABLE 170 PCR TECHNOLOGIES MARKET: DEALS, JANUARY 2021–AUGUST 2024
TABLE 171 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 172 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 173 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
TABLE 174 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2024
TABLE 175 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 176 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 177 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
TABLE 178 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–AUGUST 2024
TABLE 179 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 180 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 181 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 182 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–AUGUST 2024
TABLE 183 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 184 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 185 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 186 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2024
TABLE 187 QIAGEN: COMPANY OVERVIEW
TABLE 188 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 189 QIAGEN: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
TABLE 190 QIAGEN: DEALS, JANUARY 2021–AUGUST 2024
TABLE 191 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 192 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 193 DANAHER CORPORATION: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
TABLE 194 DANAHER CORPORATION: DEALS, JANUARY 2021– AUGUST 2024
TABLE 195 ABBOTT: COMPANY OVERVIEW
TABLE 196 ABBOTT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 197 ABBOTT: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
TABLE 198 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 199 TAKARA BIO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 200 TAKARA BIO INC.: DEALS, JANUARY 2021– AUGUST 2024
TABLE 201 ANALYTIK JENA GMBH+CO. KG: COMPANY OVERVIEW
TABLE 202 ANALYTIK JENA GMBH+CO. KG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 203 ANALYTIK JENA GMBH+CO. KG: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2024
TABLE 204 ANALYTIK JENA GMBH+CO. KG: DEALS, JANUARY 2021– AUGUST 2024
TABLE 205 MERCK KGAA: COMPANY OVERVIEW
TABLE 206 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 207 BIONEER CORPORATION: COMPANY OVERVIEW
TABLE 208 BIONEER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 209 PERKINELMER: COMPANY OVERVIEW
TABLE 210 PERKINELMER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 211 PERKINELMER: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024
TABLE 212 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 213 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 214 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
TABLE 215 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–AUGUST 2024
TABLE 216 STANDARD BIOTOOLS: COMPANY OVERVIEW
TABLE 217 STANDARD BIOTOOLS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 218 HOLOGIC, INC.: COMPANY OVERVIEW
TABLE 219 HOLOGIC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 220 HOLOGIC, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 221 LONZA: COMPANY OVERVIEW
TABLE 222 LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 223 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 224 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 225 SANSURE BIOTECH INC.: COMPANY OVERVIEW
TABLE 226 SANSURE BIOTECH INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 227 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 228 LIMINGBIO: COMPANY OVERVIEW
TABLE 229 EPPENDORF SE: COMPANY OVERVIEW
TABLE 230 TRANSGEN BIOTECH CO., LTD.: COMPANY OVERVIEW
TABLE 231 DAAN GENE CO., LTD.: COMPANY OVERVIEW
TABLE 232 BIOBASE GROUP: COMPANY OVERVIEW
TABLE 233 NIPPON GENETICS EUROPE: COMPANY OVERVIEW
TABLE 234 BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 235 DAIICHI SANKYO COMPANY, LIMITED: COMPANY OVERVIEW
TABLE 236 STILLA: COMPANY OVERVIEW
TABLE 237 GENSCRIPT: COMPANY OVERVIEW

LIST OF FIGURES

FIGURE 1 PCR TECHNOLOGIES MARKET: SEGMENTS CONSIDERED
FIGURE 2 PCR TECHNOLOGIES MARKET: YEARS CONSIDERED
FIGURE 3 PCR TECHNOLOGIES MARKET: RESEARCH DATA
FIGURE 4 PCR TECHNOLOGIES MARKET: RESEARCH DESIGN
FIGURE 5 PCR TECHNOLOGIES MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 6 PCR TECHNOLOGIES MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES)
FIGURE 7 PCR TECHNOLOGIES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 9 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 10 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 11 PCR TECHNOLOGIES MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
FIGURE 12 PCR TECHNOLOGIES MARKET: BOTTOM-UP APPROACH
FIGURE 13 PCR TECHNOLOGIES MARKET: TOP-DOWN APPROACH
FIGURE 14 DATA TRIANGULATION METHODOLOGY
FIGURE 15 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS
FIGURE 16 PCR TECHNOLOGIES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
FIGURE 17 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2024 VS. 2030 (USD MILLION)
FIGURE 18 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
FIGURE 19 PCR TECHNOLOGIES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
FIGURE 20 PCR TECHNOLOGIES MARKET: REGIONAL SNAPSHOT
FIGURE 21 INCREASING DEMAND FOR ADVANCED PCR TECHNOLOGIES TO DRIVE MARKET
FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
FIGURE 23 US AND DIAGNOSTIC LABORATORIES COMMANDED LARGEST MARKET SHARE IN 2023
FIGURE 24 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2030
FIGURE 25 PCR TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 26 PCR TECHNOLOGIES MARKET: VALUE CHAIN ANALYSIS
FIGURE 27 PCR TECHNOLOGIES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
FIGURE 29 KEY BUYING CRITERIA FOR TOP FOUR END USERS
FIGURE 30 PATENT ANALYSIS FOR PCR TECHNOLOGIES (JANUARY 2014–AUGUST 2024)
FIGURE 31 AVERAGE SELLING PRICE TREND OF PCR TECHNOLOGY EQUIPMENT, BY REGION, 2021–2023 (USD)
FIGURE 32 AVERAGE SELLING PRICE OF PCR INSTRUMENTS, BY KEY PLAYER, 2023 (USD)
FIGURE 33 PCR TECHNOLOGIES MARKET: ECOSYSTEM ANALYSIS
FIGURE 34 PCR TECHNOLOGIES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 35 PCR TECHNOLOGIES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 36 INVESTMENT AND FUNDING SCENARIO, 2019–2023
FIGURE 37 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
FIGURE 38 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
FIGURE 39 PCR TECHNOLOGIES MARKET: IMPACT OF AI/GEN AI
FIGURE 40 NORTH AMERICA: PCR TECHNOLOGIES MARKET SNAPSHOT
FIGURE 41 ASIA PACIFIC: PCR TECHNOLOGIES MARKET SNAPSHOT
FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN PCR TECHNOLOGIES MARKET (2019–2023)
FIGURE 43 PCR INSTRUMENTS MARKET SHARE ANALYSIS (2023)
FIGURE 44 PCR REAGENTS AND CONSUMABLES MARKET SHARE ANALYSIS (2023)
FIGURE 45 PCR SOFTWARE AND SERVICES MARKET SHARE ANALYSIS (2023)
FIGURE 46 PCR TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 47 PCR TECHNOLOGIES MARKET: COMPANY FOOTPRINT
FIGURE 48 PCR TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 49 EV/EBITDA OF KEY VENDORS
FIGURE 50 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 51 PCR TECHNOLOGIES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 53 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 54 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 56 QIAGEN: COMPANY SNAPSHOT
FIGURE 57 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 58 ABBOTT: COMPANY SNAPSHOT
FIGURE 59 TAKARA BIO INC.: COMPANY SNAPSHOT
FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 61 BIONEER CORPORATION: COMPANY SNAPSHOT
FIGURE 62 PERKINELMER: COMPANY SNAPSHOT
FIGURE 63 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 64 STANDARD BIOTOOLS: COMPANY SNAPSHOT
FIGURE 65 HOLOGIC, INC.: COMPANY SNAPSHOT
FIGURE 66 LONZA: COMPANY SNAPSHOT
FIGURE 67 ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 68 SANSURE BIOTECH INC.: COMPANY SNAPSHOT

Major activities have been focused to estimate the market size of the PCR technologies sector at present. Extensive secondary research has been conducted to collate information regarding the PCR industry. The next step involved primary research with industry experts along the value chain to validate these findings, assumptions, and market sizing. Many different methodologies were used for estimating the overall market size, involving the top-down and bottom-up approaches. To do so, we employed market segmentation and data triangulation techniques to get an accurate market size across different market segments and subsegments of the PCR technologies market.

Secondary Research

Secondary research sources of this study include directories and databases, such as D&B Hoovers and Factiva; white papers; Bloomberg Businessweek; annual reports; SEC filings; business filings; and investor presentations. The above sources have given information on leading companies and market segmentation that reflects the industry trend and technological perspectives of the PCR technologies market .

Primary Research

Major research activities entailed interviewing the supply side and the demand side, using both a quantitative and qualitative approach to data collection. Supply side information was obtained from key informants like CEOs, area sales managers, territory sales managers, regional sales managers, and other high-level officials from leading companies, while on the demand side, it mainly comprised physicians, researchers, department heads, and staff from diagnostic centers, hospitals, and research institutions. This study was conducted for the purpose of ensuring that assumptions were validated through interaction with relevant stakeholders.

A breakdown of the primary respondents is provided below:

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

This research involves revenue sharing review of the leading players in the PCR technologies market. Primary and secondary research methods were adopted to determine the key players in the industry and to gain some level of understanding of their financial performance and market share. The primary research was more detailed interviews taken from the CEOs, directors, and senior marketing executives, whereas the secondary research primarily relied upon the annual and financial reports issued by the major players in the industry. A segment-based strategy was followed to determine the market value across the globe, and the revenue details of the leading solution providers were further used to differentiate between sources and services.

Procedures Covered:

Identify the companies around the world who are leading PCR technologies industry and note down their respective annual revenues or specific product category/business division.

The revenue mapping of the key competitors, based on 2024, is in fact a major share of the market for this analysis, thus extrapolated to total global value for the PCR technologies market.

Data Triangulation

The PCR technologies market is segmented into various segments and subsegments based on the methodology adopted in this report. Data triangulation and the segmentation process are next undertaken to ensure the accuracy of data for all segments. Drivers and trends have been identified from both the supply and demand sides. The results obtained from both the top-down and bottom-up approaches have been utilized for deriving the results of the PCR technologies market analysis.

Market Definition

The PCR (Polymerase Chain Reaction) technologies market involves the biotechnology and health industries specializing in product and service offerings related to PCR techniques. PCR is a molecular biology technique allowing targeted amplification of DNA sequences so that genetic material may be examined. This market encompasses several sub-components, including the equipment, like thermal cyclers and real-time PCR machines, and consumables, including reagents, enzymes, primers, and kits, for the PCR process. Applications of PCR include research, clinical diagnostics, genetic testing, forensic analysis, and environmental studies. Among the driving factors behind this market are technological developments, including digital PCR and multiplex PCR that advance sensitivity and specificity in instruments. Future growth in the market is expected due to increased research activities, increased incidence of genetic disorders, and continuous innovative developments in biotechnology.

Stakeholders

Manufacturers and distributors of PCR Technologies devices
Healthcare institutions (hospitals and clinics)
Diagnostic centers
Healthcare institutions (hospital Labs)
Research institutions.
Research and consulting firms.
Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
Academic medical centers and universities
Market research and consulting firms
Clinical research organizations
Pharma-Biotech Companies
Group Purchasing Organizations (GPOs)
Medical Research Laboratories
Academic Medical Centers and Universities
Accountable Care Organizations (ACOs)

Report Objectives

To define, describe, and forecast the global PCR Technologies market based on product, application, technique, end user, and region.
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To profile the key market players and comprehensively analyze their market shares and core competencies2
To forecast the revenue of the market segments in five main regions: North America (the US and Canada), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
To track and analyze competitive developments such as product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the PCR Technologies market.

Previous Versions of this Report

PCR Technologies Market by Technique (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene Expression, Diagnostics), End User (Academia, Pharma-Biotech, Applied) - Global Forecast to 2027

Report Code AST 7880

Published in Nov, 2022, By MarketsandMarkets™

PCR Technologies Market by Technique (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene Expression, Diagnostics), End User (Academia, Pharma-Biotech, Applied) - Global Forecast to 2027

Report Code AST 7880

Published in Apr, 2021, By MarketsandMarkets™

PCR Technologies Market: Growth, Size, Share, and Trends

PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), End-user (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030

Overview

Attractive Opportunities in the PCR Technologies Market

North America

Global PCR Technologies Market Dynamics

Driving Forces: Technological Advancement

Restraining Factors: High Costs of Equipment

Opportunities: Emerging Application of PCR Technology

Challenges: Inhibition and Sensitivity

Global PCR Technologies Market Ecosystem Analysis

Reagents and consumables to register most significant market share during study period

Diagnostic laboratories to hold largest share in end-user market from 2024 to 2030

Asia Pacific register highest CAGR in PCR technologies market during forecast period

Recent Developments of PCR Technologies Market

Key Market Players

Want to explore hidden markets that can drive new revenue in PCR Technologies Market? Unlock Insights Scope of the Report

Want to explore hidden markets that can drive new revenue in PCR Technologies Market?

Key Questions Addressed by the Report

Adjacent Markets

Personalize This Research

Let Us Help You

Table of Contents

Secondary Research

Primary Research

Market Size Estimation

Procedures Covered:

Data Triangulation

Market Definition

Stakeholders

Report Objectives

Previous Versions of this Report

PCR Technologies Market by Technique (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene Expression, Diagnostics), End User (Academia, Pharma-Biotech, Applied) - Global Forecast to 2027

PCR Technologies Market by Technique (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene Expression, Diagnostics), End User (Academia, Pharma-Biotech, Applied) - Global Forecast to 2027

Custom Market Research Services

Growth opportunities and latent adjacency in PCR Technologies Market

Want to explore hidden markets that can drive new revenue in PCR Technologies Market?

Unlock Insights

Scope of the Report